ArticleFrontiers in immunology2026
GRHL2 contributes to the maintenance of intestinal epithelial barrier integrity during LPS-induced injury.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sepsis-induced intestinal epithelial barrier dysfunction contributes to gastrointestinal injury during critical illness, yet the molecular mechanisms underlying barrier disruption remain incompletely understood. This study investigated the potential involvement of Grainyhead-like 2 (GRHL2) in lipopolysaccharide (LPS)-induced intestinal epithelial barrier injury. Methods: LPS-induced intestinal barrier injury was evaluated using Caco-2 monolayers and a mouse endotoxemia model. Barrier integrity was assessed by transepithelial electrical resistance (TEER), immunofluorescence, histological analysis, serum cytokine measurement, and FITC-dextran permeability assays. Transcriptomic analysis was performed to identify biological processes associated with LPS-induced intestinal injury. GRHL2 expression was evaluated by qRT-PCR, immunohistochemistry, and Western blotting. Gain- and loss-of-function experiments were performed using lentiviral-mediated GRHL2 overexpression and knockdown Results: LPS exposure impaired epithelial barrier integrity, as evidenced by reduced TEER values, disrupted Occludin distribution, increased serum TNF-α and IL-6 concentrations, histological injury, and enhanced intestinal permeability. Transcriptomic analysis revealed marked transcriptional alterations following LPS exposure, with enrichment of biological processes related to inflammatory responses, cell-cell adhesion, epithelial development, and extracellular matrix organization. GRHL2 expression was significantly reduced in LPS-treated intestinal tissues together with decreased expression of several epithelial junction-associated molecules, including E-cadherin, Claudin-3, Claudin-4, and Occludin. Functional modulation demonstrated that GRHL2 knockdown aggravated intestinal injury and permeability, whereas GRHL2 overexpression attenuated barrier dysfunction and was accompanied by increased expression of multiple epithelial junction-associated molecules. Discussion: These findings demonstrate that GRHL2 contributes to the maintenance of intestinal epithelial barrier integrity during LPS-induced injury. The observed association between GRHL2 downregulation and impaired expression of epithelial junction-associated molecules suggests that GRHL2 may participate in the epithelial response to inflammatory injury. Further studies are required to clarify the molecular mechanisms underlying GRHL2 regulation and its role in intestinal barrier homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.